Cost effectiveness of screening for and eradication of Helicobacter pylori in young patients with dyspepsia. Comparison groups were not clear in study.
作者信息
Tham T C, Lichtenstein D R
出版信息
BMJ. 1996 Sep 7;313(7057):623. doi: 10.1136/bmj.313.7057.623.
Abstract
摘要
相似文献
1
Cost effectiveness of screening for and eradication of Helicobacter pylori in young patients with dyspepsia. Comparison groups were not clear in study.年轻消化不良患者幽门螺杆菌筛查与根除的成本效益。研究中对照组不明确。
BMJ. 1996 Sep 7;313(7057):623. doi: 10.1136/bmj.313.7057.623.
2
Cost effectiveness of screening for and eradication of Helicobacter pylori in young patients with dyspepsia. Costs will probably vary according to local data.年轻消化不良患者幽门螺杆菌筛查及根除的成本效益。成本可能因当地数据而异。
BMJ. 1996 Sep 7;313(7057):622; author reply 623. doi: 10.1136/bmj.313.7057.622a.
3
Cost effectiveness of screening for and eradication of Helicobacter pylori in young patients with dyspepsia. Analysis is easier with spreadsheets than decision trees.年轻消化不良患者幽门螺杆菌筛查与根除的成本效益。使用电子表格进行分析比使用决策树更容易。
BMJ. 1996 Sep 7;313(7057):622; author reply 623. doi: 10.1136/bmj.313.7057.622.
4
Cost effectiveness of screening for and eradication of Helicobacter pylori in young patients with dyspepsia. Cost of eradication treatment may have been overestimated.对年轻消化不良患者进行幽门螺杆菌筛查和根除的成本效益。根除治疗的成本可能被高估了。
BMJ. 1996 Sep 7;313(7057):622. doi: 10.1136/bmj.313.7057.622b.
5
Cost effectiveness of screening for and eradication of Helicobacter pylori in young patients with dyspepsia. Studies'assumptions are removed from clinical practice.年轻消化不良患者幽门螺杆菌筛查及根除的成本效益。研究假设脱离了临床实践。
BMJ. 1996 Sep 7;313(7057):622-3. doi: 10.1136/bmj.313.7057.622c.
6
Population-based and opportunistic screening and eradication of Helicobacter pylori. An analysis using trial baseline data. Leeds H. pylori Study Group.基于人群和机会性的幽门螺杆菌筛查与根除。一项使用试验基线数据的分析。利兹幽门螺杆菌研究小组。
Int J Technol Assess Health Care. 1999 Fall;15(4):649-60.
7
Cost effectiveness of screening for and eradication of Helicobacter pylori in management of dyspeptic patients under 45 years of age.45岁以下消化不良患者中幽门螺杆菌筛查及根除治疗的成本效益
BMJ. 1996 May 25;312(7042):1321-5. doi: 10.1136/bmj.312.7042.1321.
8
Helicobacter eradication versus prompt endoscopy for dyspepsia.幽门螺杆菌根除治疗与消化不良的即时内镜检查对比
Gastroenterology. 2001 Apr;120(5):1298-9. doi: 10.1016/s0016-5085(01)70290-9.
9
Helicobacter pylori and nonulcer dyspepsia.幽门螺杆菌与非溃疡性消化不良。
N Engl J Med. 1999 May 13;340(19):1509-11.
本文引用的文献
1
Cost effectiveness of screening for and eradication of Helicobacter pylori in management of dyspeptic patients under 45 years of age.45岁以下消化不良患者中幽门螺杆菌筛查及根除治疗的成本效益
BMJ. 1996 May 25;312(7042):1321-5. doi: 10.1136/bmj.312.7042.1321.
2
Initial endoscopy or empirical therapy with or without testing for Helicobacter pylori for dyspepsia: a decision analysis.消化不良患者的初始内镜检查或针对幽门螺杆菌检测与否的经验性治疗：一项决策分析
Gastroenterology. 1996 Jan;110(1):72-83. doi: 10.1053/gast.1996.v110.pm8536890.
3
Empirical H2-blocker therapy or prompt endoscopy in management of dyspepsia.经验性使用H2受体阻滞剂治疗或及时进行内镜检查以管理消化不良。
Lancet. 1994 Apr 2;343(8901):811-6. doi: 10.1016/s0140-6736(94)92023-0.
4
Alternative management strategies for patients with suspected peptic ulcer disease.疑似消化性溃疡疾病患者的替代管理策略。
Ann Intern Med. 1995 Aug 15;123(4):260-8. doi: 10.7326/0003-4819-123-4-199508150-00003.
Zotero 插件